Today: 29 April 2026
Browse Category

BSE:511218 17 December 2025 - 24 December 2025

Shriram Finance Share Price Today (24 Dec 2025): Stock Hits Fresh 52-Week High as MUFG Deal Fuels Rerating — Analyst Targets Up to ₹1,225

Shriram Finance Share Price Today (24 Dec 2025): Stock Hits Fresh 52-Week High as MUFG Deal Fuels Rerating — Analyst Targets Up to ₹1,225

Shriram Finance traded near ₹977 midday Wednesday, hitting a new 52-week high after MUFG agreed to acquire a 20% stake for $4.4 billion. The deal, via a preferential issue at ₹840.93 per share, awaits shareholder and regulatory approval. An EGM is set for January 14, 2026. MUFG will get minority protection rights and pay a $200 million non-compete fee to Shriram Ownership Trust.
Shriram Finance Share Price Hits Record High on MUFG’s $4.4 Billion Stake Deal: Latest News, Analyst Targets, and Stock Outlook (Dec 22, 2025)

Shriram Finance Share Price Hits Record High on MUFG’s $4.4 Billion Stake Deal: Latest News, Analyst Targets, and Stock Outlook (Dec 22, 2025)

Shriram Finance shares surged to a record high of ₹947.70 on December 22 after Mitsubishi UFJ Financial Group agreed to invest $4.4 billion for a 20% stake via a preferential equity issue at ₹840.93 per share. The deal, pending shareholder and regulatory approvals, marks the largest cross-border investment in India’s financial sector. Shriram Finance will seek shareholder approval at an EGM on January 14, 2026.
Shriram Finance Share Price Outlook (Dec 21, 2025): MUFG’s $4.4 Billion Stake Deal, Analyst Targets, and What Happens Next

Shriram Finance Share Price Outlook (Dec 21, 2025): MUFG’s $4.4 Billion Stake Deal, Analyst Targets, and What Happens Next

Japan’s MUFG will acquire a 20% stake in Shriram Finance for about $4.4 billion via a preferential allotment, pending shareholder and regulatory approval. Shriram Finance shares surged to record highs Friday, closing near ₹901.7. The deal includes a $200 million non-compete fee for Shriram Ownership Trust and grants MUFG minority protection rights and board representation. An EGM is set for January 14, 2026.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 3:00 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop